ATE417059T1 - Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente - Google Patents

Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente

Info

Publication number
ATE417059T1
ATE417059T1 AT00958898T AT00958898T ATE417059T1 AT E417059 T1 ATE417059 T1 AT E417059T1 AT 00958898 T AT00958898 T AT 00958898T AT 00958898 T AT00958898 T AT 00958898T AT E417059 T1 ATE417059 T1 AT E417059T1
Authority
AT
Austria
Prior art keywords
ligand
toxin
highly pure
producing highly
pure non
Prior art date
Application number
AT00958898T
Other languages
English (en)
Inventor
John A Chaddock
F C G Alexander
Keith A Foster
Original Assignee
Health Prot Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Prot Agency filed Critical Health Prot Agency
Application granted granted Critical
Publication of ATE417059T1 publication Critical patent/ATE417059T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT00958898T 1999-09-13 2000-09-13 Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente ATE417059T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9921592.3A GB9921592D0 (en) 1999-09-13 1999-09-13 Preparation of highly pure toxin fragments

Publications (1)

Publication Number Publication Date
ATE417059T1 true ATE417059T1 (de) 2008-12-15

Family

ID=10860807

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00958898T ATE417059T1 (de) 1999-09-13 2000-09-13 Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente

Country Status (7)

Country Link
US (1) US7193066B1 (de)
EP (1) EP1212361B1 (de)
AT (1) ATE417059T1 (de)
AU (1) AU7030700A (de)
DE (1) DE60041067D1 (de)
GB (1) GB9921592D0 (de)
WO (1) WO2001019863A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192596B2 (en) * 1996-08-23 2007-03-20 The Health Protection Agency Ipsen Limited Recombinant toxin fragments
GB9617671D0 (en) * 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
US8012491B2 (en) * 1996-08-23 2011-09-06 Syntaxin, Ltd. Recombinant toxin fragments
US7368532B2 (en) 1999-12-02 2008-05-06 Syntaxin Limited Constructs for delivery of therapeutic agents to neuronal cells
AU2010214834B2 (en) 2009-02-19 2016-04-14 Merz Pharma Gmbh & Co. Kgaa Means and methods for manufacturing highly pure neurotoxin
GB0903006D0 (en) 2009-02-23 2009-04-08 Syntaxin Ltd Modified non-cytotoxic proteases
US20120196349A1 (en) * 2009-10-21 2012-08-02 Revance Therapeutics, Inc. Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin
KR20110046178A (ko) * 2009-10-28 2011-05-04 엘지전자 주식회사 이동 단말기
KR101134146B1 (ko) * 2010-05-31 2012-04-19 메덱스젠 주식회사 국소 근마비 효과를 갖는 비확산형 보툴리눔 독소와 그의 정제방법
CN109206286A (zh) * 2018-11-02 2019-01-15 南京理工大学 一种可用作起爆药的胶囊结构铝热剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601826A (en) 1989-06-30 1997-02-11 The United States Of America As Represented By The Department Of Health And Human Services Peptide which produces protective immunity against tetanus
DE4037809A1 (de) * 1990-11-28 1992-06-04 Yehia Mohammed Yousif Anwendungen von staphylokokkal neutrale phosphatase und 70 kd protein
HUT78048A (hu) 1994-10-24 1999-07-28 Ophidian Pharmaceuticals, Inc. A C. difficile által okozott betegség kezelésére és megelőzésére szolgáló vakcina és antitoxin
ZA983690B (en) * 1998-04-02 1999-02-04 Synsorb Biotech Inc Solid support matrices containing a toxin binding oligosaccharide

Also Published As

Publication number Publication date
AU7030700A (en) 2001-04-17
US7193066B1 (en) 2007-03-20
GB9921592D0 (en) 1999-11-17
DE60041067D1 (de) 2009-01-22
EP1212361A1 (de) 2002-06-12
WO2001019863A1 (en) 2001-03-22
EP1212361B1 (de) 2008-12-10

Similar Documents

Publication Publication Date Title
DE60009511D1 (de) Nematizide trifluorbutene
BR0316375A (pt) Diazinopirimidinas
DE60114002D1 (de) VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION
DE69527696T2 (de) Kristalline Paclitaxel Hydrate
DE60022230D1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
CY1108808T1 (el) Ενωσεις μοτιλιδης
ATE198834T1 (de) Konjugate bestehend aus polysaccharid und protein
EP1242115A4 (de) Chemisch programmierbare immunität
ATE417059T1 (de) Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente
DE69625354D1 (de) Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen
BR0109975A (pt) Método para produzir ansamitocinas
DK1207870T3 (da) Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf
SE0003476D0 (sv) Compounds
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
DE69717843T2 (de) Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
ATE187461T1 (de) Cyklopeptolide
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
ID27440A (id) Proses untuk menyiapkan penengah-penengah
PT1276722E (pt) Inibidores de naftamidina-uroquinase
PT1181300E (pt) Derivados 6-o-carbamato de cetolido
WO2001068066A3 (en) A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
ATE397615T1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
WO2005030148A3 (en) Tetrahydroindolone derivatives for treatment of neurological conditions
DK1035860T3 (da) Ikke-toksiske immunstimulerende enterotoksinsammensætninger
PT777471E (pt) Metodo de inibicao da biosintese de leucotrieno

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties